Cinctive Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-39,040	Closed	-$600K	–	327
2024 Q3	$600K	Sell	39,040 -5,338	-12%	-$82.1K	0.03%	315
2024 Q2	$721K	Buy	+44,378	New	+$721K	0.03%	309
2020 Q4	–	Sell	-47,346	Closed	-$1.95M	–	310
2020 Q3	$1.95M	Buy	+47,346	New	+$1.95M	0.17%	205